Phase III study of StrataGraft regenerative tissue meets both primary endpoints Sep. 25, 2019 No Comments
Bristol-Myers Squibb designs RORgammaT inverse agonists showing biologic-like efficacy Sep. 9, 2019 No Comments
Krystal Biotech initiates phase I/II study of topical KB-105 gene therapy for TGM1-deficient ARCI Sep. 2, 2019 No Comments
Phase III BREEZE-AD7 study of baricitinib in atopic dermatitis meets primary endpoint Aug. 26, 2019 No Comments
Complete wound healing reported in first patient treated in phase II study of RGN-137 Aug. 6, 2019 No Comments
Sanofi reports updates for Dupixent as treatment in adolescents and children with atopic dermatitis Aug. 6, 2019 No Comments
RSS